Dr. Dana Bonezzi, MD

NPI: 1255331542
Total Payments
$5,789
2024 Payments
$890.19
Companies
50
Transactions
396
Medicare Patients
1,932
Medicare Billing
$151,451

Payment Breakdown by Category

Food & Beverage$5,781 (99.9%)
Education$8.35 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $5,781 395 99.9%
Education $8.35 1 0.1%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $866.08 59 $0 (2024)
Novo Nordisk Inc $811.13 83 $0 (2024)
Lilly USA, LLC $456.49 36 $0 (2024)
AstraZeneca Pharmaceuticals LP $352.69 19 $0 (2024)
Amgen Inc. $295.43 21 $0 (2024)
Merck Sharp & Dohme LLC $288.21 20 $0 (2024)
PFIZER INC. $235.77 14 $0 (2024)
Radius Health, Inc. $230.06 13 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $206.90 13 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $175.87 10 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $890.19 44 ABBVIE INC. ($267.66)
2023 $662.68 39 AbbVie Inc. ($166.80)
2022 $666.85 47 Novo Nordisk Inc ($135.99)
2021 $728.32 49 AbbVie Inc. ($178.66)
2020 $322.27 21 AbbVie Inc. ($60.78)
2019 $792.62 60 PFIZER INC. ($133.55)
2018 $761.69 64 Novo Nordisk Inc ($113.33)
2017 $964.40 72 Novo Nordisk Inc ($201.72)

All Payment Transactions

396 individual payment records from CMS Open Payments — Page 1 of 16

Date Company Product Nature Form Amount Type
11/08/2024 Optinose US, Inc. Xhance (Drug) Food and Beverage In-kind items and services $20.14 General
Category: Otolaryngology (Ear, Nose, Throat)
10/28/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $27.17 General
Category: NEUROSCIENCE
10/24/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $13.68 General
Category: Cardio-renal
10/22/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $19.65 General
Category: Diabetes
09/30/2024 PFIZER INC. ELIQUIS (Drug), NURTEC ODT Food and Beverage In-kind items and services $16.91 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
09/12/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $11.20 General
Category: NEUROSCIENCE
09/11/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $13.97 General
Category: NEUROSCIENCE
09/09/2024 Merck Sharp & Dohme LLC GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 Food and Beverage In-kind items and services $20.85 General
Category: VACCINE
09/06/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $22.81 General
Category: NEUROSCIENCE
08/29/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $10.08 General
Category: NEUROSCIENCE
08/26/2024 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $14.27 General
Category: Cardiovascular
08/19/2024 Hologic Sales and Service, LLC APTIMA (Device) Food and Beverage In-kind items and services $18.98 General
Category: Diagnostics
08/09/2024 Amgen Inc. EVENITY (Biological), Prolia Food and Beverage In-kind items and services $18.01 General
Category: Bone Health
08/02/2024 Boehringer Ingelheim Pharmaceuticals, Inc. OFEV (Drug) Food and Beverage In-kind items and services $19.50 General
Category: RESPIRATORY
07/19/2024 Xeris Pharmaceuticals, Inc. GVOKE HYPOPEN (Drug) Food and Beverage In-kind items and services $19.63 General
Category: Diabetes
07/12/2024 ABBVIE INC. UBRELVY (Drug) Food and Beverage In-kind items and services $23.91 General
Category: NEUROSCIENCE
07/08/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $15.85 General
Category: Gastroenterology
06/24/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $20.87 General
Category: Respiratory
06/13/2024 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage In-kind items and services $18.28 General
Category: Diabetes
06/08/2024 Astellas Pharma US Inc Veozah (Drug) Food and Beverage In-kind items and services $15.38 General
Category: Biological
05/22/2024 Abbott Laboratories FREESTYLE LIBRE 2 (Device) Food and Beverage In-kind items and services $20.49 General
Category: Diabetes Care
05/20/2024 Exact Sciences Corporation Cologuard Collection Kit (Device) Food and Beverage In-kind items and services $23.61 General
Category: Oncology
05/13/2024 ABBVIE INC. UBRELVY (Drug) Food and Beverage In-kind items and services $24.82 General
Category: NEUROSCIENCE
05/10/2024 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage In-kind items and services $16.58 General
Category: Diabetes
04/29/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $13.59 General
Category: Cardio-renal

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 11 362 596 $58,165 $33,651
2022 15 513 841 $74,945 $40,677
2021 15 550 995 $78,915 $41,671
2020 15 507 925 $72,435 $35,452
Total Patients
1,932
Total Services
3,357
Medicare Billing
$151,451
Procedure Codes
56

All Medicare Procedures & Services

56 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 101 236 $33,040 $20,046 60.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 61 95 $10,925 $6,034 55.2%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 19 19 $3,420 $2,382 69.7%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 46 57 $3,990 $2,005 50.3%
G0008 Administration of influenza virus vaccine Office 2023 30 30 $1,050 $880.80 83.9%
20605 Aspiration and/or injection of fluid from medium joint Office 2023 11 19 $1,520 $762.03 50.1%
90688 Influenza vaccine, quadrivalent, 0.5 ml dosage Office 2023 32 32 $1,280 $654.72 51.2%
87811 Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) Office 2023 11 11 $825.00 $446.05 54.1%
83036 Hemoglobin a1c level Office 2023 25 37 $1,295 $352.24 27.2%
81002 Urinalysis, manual test Office 2023 14 16 $160.00 $54.56 34.1%
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg Office 2023 12 44 $660.00 $32.76 5.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 113 225 $31,500 $18,494 58.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 79 126 $14,490 $7,744 53.4%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 32 32 $5,760 $4,049 70.3%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2022 70 111 $7,770 $3,888 50.0%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 13 13 $2,600 $1,574 60.5%
20610 Aspiration and/or injection of fluid from large joint Office 2022 12 32 $3,200 $1,127 35.2%
87811 Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) Office 2022 22 22 $1,650 $886.94 53.8%
G0008 Administration of influenza virus vaccine Office 2022 30 30 $1,050 $838.50 79.9%
90688 Influenza vaccine, quadrivalent, 0.5 ml dosage Office 2022 31 31 $1,240 $622.17 50.2%
83036 Hemoglobin a1c level Office 2022 37 57 $1,995 $546.46 27.4%
87804 Detection test by immunoassay with direct visual observation for influenza virus Office 2022 13 26 $910.00 $427.99 47.0%
96372 Injection of drug or substance under skin or into muscle Office 2022 11 23 $805.00 $196.40 24.4%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2022 18 19 $665.00 $152.84 23.0%
81002 Urinalysis, manual test Office 2022 18 20 $200.00 $68.84 34.4%

About Dr. Dana Bonezzi, MD

Dr. Dana Bonezzi, MD is a Internal Medicine healthcare provider based in Wooster, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1255331542.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dana Bonezzi, MD has received a total of $5,789 in payments from pharmaceutical and medical device companies, with $890.19 received in 2024. These payments were reported across 396 transactions from 50 companies. The most common payment nature is "Food and Beverage" ($5,781).

As a Medicare-enrolled provider, Bonezzi has provided services to 1,932 Medicare beneficiaries, totaling 3,357 services with total Medicare billing of $151,451. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Location Wooster, OH
  • Active Since 07/28/2005
  • Last Updated 04/01/2020
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1255331542

Products in Payments

  • Ozempic (Drug) $352.55
  • UBRELVY (Drug) $317.78
  • JARDIANCE (Drug) $255.71
  • FARXIGA (Drug) $241.02
  • XIFAXAN (Drug) $231.78
  • VRAYLAR (Drug) $209.72
  • Victoza (Drug) $204.93
  • MOUNJARO (Drug) $179.71
  • ELIQUIS (Drug) $167.65
  • AFREZZA (Drug) $147.31
  • Tymlos (Drug) $129.05
  • JANUVIA (Drug) $123.28
  • QULIPTA (Drug) $103.65
  • Tymlos (Biological) $101.01
  • TRINTELLIX (Drug) $96.31
  • VYNDAQEL (Drug) $93.20
  • Kerendia (Drug) $92.53
  • Vascepa (Drug) $87.89
  • Prolia (Biological) $86.94
  • EMGALITY (Drug) $80.16

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Wooster